Plasmablastic lymphoma: successful management with CHOP and lenalidomide in resource constraint settings.
Department of Internal Medicine (Clinical Hematology Division), PGIMER, Chandigarh, 160012, India.
Uday
U
Yanamandra
Department of Internal Medicine (Clinical Hematology Division), PGIMER, Chandigarh, 160012, India.
Kamal Kant
KK
Sahu
Department of Internal Medicine (Clinical Hematology Division), PGIMER, Chandigarh, 160012, India.
Nidhi
N
Jain
Department of Internal Medicine (Clinical Hematology Division), PGIMER, Chandigarh, 160012, India.
Gaurav
G
Prakash
Department of Histopathology, P.G.I.M.E.R, Chandigarh. U.T, 160012, India.
Uma
U
Saikia
Department of Internal Medicine (Clinical Hematology Division), PGIMER, Chandigarh, 160012, India. hematpgi@gmail.com.
Pankaj
P
Malhotra
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy*; D008444:Maxillary Sinus Neoplasms / Q000188:drug therapy*; D000069293:Plasmablastic Lymphoma / Q000188:drug therapy*; D011203:Poverty; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D014750:Vincristine / Q000008:administration & dosage
D013792:Thalidomide; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D000077269:Lenalidomide